Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Systematic review of the quality of prognosis studies in systemic lupus erythematosus.

Lim LS, Lee SJ, Feldman BM, Gladman DD, Pullenayegum E, Uleryk E, Silverman ED.

Arthritis Care Res (Hoboken). 2014 Oct;66(10):1536-41. doi: 10.1002/acr.22322. Review.

2.

Prognosis and treatment of systemic lupus erythematosus.

Gladman DD.

Curr Opin Rheumatol. 1996 Sep;8(5):430-7. Review.

PMID:
8941446
3.

Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis.

Bizzaro N, Villalta D, Giavarina D, Tozzoli R.

Autoimmun Rev. 2012 Dec;12(2):97-106. doi: 10.1016/j.autrev.2012.07.002. Epub 2012 Jul 15. Review.

PMID:
22810055
4.

A systematic review of validated methods for identifying systemic lupus erythematosus (SLE) using administrative or claims data.

Moores KG, Sathe NA.

Vaccine. 2013 Dec 30;31 Suppl 10:K62-73. doi: 10.1016/j.vaccine.2013.06.104. Review.

PMID:
24331075
5.

Prognostic factors for survival in systemic lupus erythematosus associated pulmonary hypertension.

Chow SL, Chandran V, Fazelzad R, Johnson SR.

Lupus. 2012 Apr;21(4):353-64. doi: 10.1177/0961203311429815. Epub 2011 Nov 29. Review.

PMID:
22127457
6.

Predictive and prognostic factors influencing outcomes of rituximab therapy in systemic lupus erythematosus (SLE): A systematic review.

Pirone C, Mendoza-Pinto C, van der Windt DA, Parker B, O Sullivan M, Bruce IN.

Semin Arthritis Rheum. 2017 May 5. pii: S0049-0172(17)30099-9. doi: 10.1016/j.semarthrit.2017.04.010. [Epub ahead of print]

7.

Evaluation of the quality of prognosis studies in systematic reviews.

Hayden JA, Côté P, Bombardier C.

Ann Intern Med. 2006 Mar 21;144(6):427-37.

PMID:
16549855
8.

Outcome measures to be used in clinical trials in systemic lupus erythematosus.

Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P.

J Rheumatol. 1999 Feb;26(2):490-7.

PMID:
9972993
9.

Design, quality, and bias in randomized controlled trials of systemic lupus erythematosus.

Karassa FB, Tatsioni A, Ioannidis JP.

J Rheumatol. 2003 May;30(5):979-84.

PMID:
12734892
10.

Measurement of fatigue in systemic lupus erythematosus: a systematic review.

Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria for Fatigue.

Arthritis Rheum. 2007 Dec 15;57(8):1348-57. Review.

11.

Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.

Callaghan A, Kendall G, Lock C, Mahony A, Payne J, Verrier L.

Int J Evid Based Healthc. 2005 Jul;3(6):147-67. doi: 10.1111/j.1479-6988.2005.00024.x.

PMID:
21631747
12.

The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.

American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria.

Arthritis Rheum. 2004 Nov;50(11):3418-26.

13.

Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.

Wang M, Gladman DD, Ibañez D, Urowitz MB.

Arthritis Care Res (Hoboken). 2012 Jun;64(6):833-7. doi: 10.1002/acr.21624. Epub 2012 Jan 30.

14.

Systemic lupus erythematosus: a review of the disease and treatment options.

Gurevitz SL, Snyder JA, Wessel EK, Frey J, Williamson BA.

Consult Pharm. 2013 Feb;28(2):110-21. doi: 10.4140/TCP.n.2013.110. Review.

PMID:
23395811
15.

Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review.

Langer-Gould A, Popat RA, Huang SM, Cobb K, Fontoura P, Gould MK, Nelson LM.

Arch Neurol. 2006 Dec;63(12):1686-91. Review.

PMID:
17172607
16.

Identification of clinical predictors of flare in systemic lupus erythematosus patients: a 24-month prospective cohort study.

Inês L, Duarte C, Silva RS, Teixeira AS, Fonseca FP, da Silva JA.

Rheumatology (Oxford). 2014 Jan;53(1):85-9. doi: 10.1093/rheumatology/ket322. Epub 2013 Sep 24.

PMID:
24067885
17.

Association of discoid lupus erythematosus with other clinical manifestations among patients with systemic lupus erythematosus.

Merola JF, Prystowsky SD, Iversen C, Gomez-Puerta JA, Norton T, Tsao P, Massarotti E, Schur P, Bermas B, Costenbader KH.

J Am Acad Dermatol. 2013 Jul;69(1):19-24. doi: 10.1016/j.jaad.2013.02.010. Epub 2013 Mar 28.

18.

The humanistic and economic burden of systemic lupus erythematosus : a systematic review.

Meacock R, Dale N, Harrison MJ.

Pharmacoeconomics. 2013 Jan;31(1):49-61. doi: 10.1007/s40273-012-0007-4. Review.

PMID:
23329592
19.

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.

Bertsias G, Ioannidis JP, Boletis J, Bombardieri S, Cervera R, Dostal C, Font J, Gilboe IM, Houssiau F, Huizinga T, Isenberg D, Kallenberg CG, Khamashta M, Piette JC, Schneider M, Smolen J, Sturfelt G, Tincani A, van Vollenhoven R, Gordon C, Boumpas DT; Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.

Ann Rheum Dis. 2008 Feb;67(2):195-205. Epub 2007 May 15.

20.

Prognosis and treatment of systemic lupus erythematosus.

Gladman DD.

Curr Opin Rheumatol. 1995 Sep;7(5):402-8. Review.

PMID:
8519613

Supplemental Content

Support Center